Coating Place — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Coating Place is the global leader in Wurster fluid bed coating technology, offering end-to-end contract research, development, and manufacturing services. With a legacy dating back to the inventor of the process, Dr. Dale E. Wurster, the company operates FDA, EMA, and DEA-licensed facilities capable of handling controlled substances and producing batches from 0.010 kg to 800 kg. Its mission is to deliver innovative, precise coating solutions with a commitment to integrity, quality, and customer partnership.

Drug Delivery

Technology Platform

Proprietary Wurster fluid bed coating technology for the precise micro-encapsulation and functional coating of particles, enabling controlled release, taste-masking, stability, and moisture protection for pharmaceuticals, nutraceuticals, and chemicals.

Opportunities

Growth is driven by increasing demand for complex drug formulations requiring specialized delivery, the expansion of the nutraceutical market, and its unique DEA licensing for handling all schedules of controlled substances, positioning it for the growing cannabinoid and opioid processing market.

Risk Factors

Key risks include dependency on client pipelines, potential technological disruption from new drug modalities, intense competition from larger CDMOs, and the ongoing operational and reputational risks associated with maintaining stringent FDA, EMA, and DEA regulatory compliance.

Competitive Landscape

Competes against large, full-service CDMOs (e.g., Catalent, Lonza) and specialized particle engineering firms (e.g., Glatt). Its differentiation lies in being the pioneer and global leader in Wurster coating technology, with proprietary scalable equipment, deep formulation expertise, and unique DEA Schedule I-V capabilities.

More companies in Drug Delivery & Formulation →More companies in United States →